Posts by Lantana Consulting Group
CDC’s National Healthcare Safety Network and Yale New Haven Health/Yale Center for Medical Informatics to Collaborate on Automated Hospital Reporting
The Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN) surveillance system and Yale New Haven Health (YNHHS)/Yale Center for Medical Informatics today announced that they are…
Read MoreLantana Awarded National Institutes of Health Contract
The National Institutes of Health (NIH) awarded Lantana Consulting Group a two-year contract working with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Read MoreImpact of coronavirus disease 2019 (COVID-19) on US Hospitals and Patients, April–July 2020
Mathew Sapiano, Erin O’Leary, and Agasha Amor co-authored an article which presents time-series estimates of the critical hospital capacity indicators from April 1 to July 14, 2020 based on data…
Read MoreDIG for Change: A Year of Diversity and Inclusion
Lantana Awarded General Services Administration Multiple Award Schedule
The General Services Administration (GSA) awarded Lantana Consulting Group a Multiple Award Schedule with Special Item Number (SIN) 54151HEAL – the consolidated solicitation SIN for Health Information Technology Services.
Read MoreIncreasing Voluntary Public Health Reporting to the NHSN Antimicrobial Use Option
Making Data Useful: A Statewide Consolidated Dataset
The Centers for Medicare and Medicaid Services (CMS) collects data from hospitals and other healthcare facilities nationwide which results in a good problem—a wealth of information without an effective way…
Read MoreNational Healthcare Safety Network Standardized Antimicrobial Administration Ratios (SAARs): A Progress Report and Risk Modeling Update Using 2017 Data
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020
Nadine Shehab, Chief Scientist, co-authored this CDC report which quantifies changes in outpatient prescriptions of hydroxychloroquine, chloroquine, and azithromycin during the COVID-19 pandemic.
Read MoreWhat is One Thing We Can Do to Improve the Use of Health Information?
What is one thing we can do to improve the use of health information? Our team weighs in.
Read MoreNon-COVID Patient Perspectives on Hospitalization During the COVID-19 Era
Navigating the healthcare system can be overwhelming during the best of times, but it’s even more challenging during a public health crisis. Seeing the impact on the news and reading…
Read MoreA Year of Stories
MIDS c3 Forum
Transfusion‐associated adverse events and implementation of blood safety measures ‐ findings from the 2017 National Blood Collection and Utilization Survey
Circumstances Involved in Unsupervised Solid Dose Medication Exposures among Young Children
A California Campaign for AUR Reporting
Sending out an S.O.S.: Learning SAS Essentials
Lantana Webinar Registration
Lantana Names Andrew Laing as Director of Information Analysis and Technology
Lantana Names Nadine Shehab as Chief Scientist
Lantana Consulting Group is pleased to announce that Nadine Shehab, PharmD, MPH has joined the company as Chief Scientist. Shehab will continue her work at the Centers for Disease Control…
Read More